- Report
- November 2022
- 111 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- April 2023
- 120 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- January 2023
- 110 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- January 2022
- 200 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- May 2020
- 100 Pages
Global
From €2768EUR$2,850USD£2,388GBP
- Report
- November 2022
- 100 Pages
Global
From €2671EUR$2,750USD£2,304GBP
- Report
- February 2023
- 166 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- April 2021
- 120 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- August 2022
- 115 Pages
Global
From €4371EUR$4,500USD£3,770GBP
- Report
- February 2021
Global
From €3093EUR$3,185USD£2,669GBP
€4419EUR$4,550USD£3,812GBP
- Report
- June 2022
- 220 Pages
Global
From €3351EUR$3,450USD£2,891GBP
- Report
- April 2023
- 117 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- April 2023
- 115 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- April 2023
- 115 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- August 2022
- 116 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- April 2021
- 51 Pages
Global
€1280EUR$1,318USD£1,104GBP
- Report
- February 2021
Global
From €2875EUR$2,960USD£2,480GBP
- Report
- February 2021
Global
From €2875EUR$2,960USD£2,480GBP
- Report
- May 2022
- 1014 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- November 2018
- 258 Pages
Global
From €7765EUR$7,995USD£6,699GBP
Lymphoma is a type of hematological malignancy that originates in the lymphatic system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell. Lymphomas can be either Hodgkin's or non-Hodgkin's, and can be either indolent or aggressive. Treatment options for lymphoma include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies.
The lymphoma market is a subset of the larger hematology market, which includes treatments for a variety of blood-related diseases. The lymphoma market is driven by the increasing prevalence of the disease, as well as the development of new treatments.
Companies in the lymphoma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more